The National Pharmaceutical Pricing Authority has issued a new price update under the Drugs Prices Control Order, 2013, acting through the Ministry of Chemicals and Fertilizers. The order fixes new retail prices for specific drug formulations submitted by manufacturers and marketing companies through Form I. These prices are exclusive of GST, which can be added only when it is officially payable.
Manufacturers should calculate pack-wise prices as per paragraph 11 of DPCO 2013 and submit the revised price list in Form V through IPDMS. A copy must also be sent to the State Drug Controller and to dealers. Retailers and dealers are required to show the updated price list in a clearly visible area of their premises, ensuring transparent access for consumers.
The notification also supersedes any previous price orders for the same formulations. Non-compliance will need manufacturers or marketers to return the overcharged amount with interest under DPCO 2013 and the Essential Commodities Act, 1955. The update reinforces pricing discipline and regulatory oversight across the pharmaceutical supply chain.